Date |
Symbol |
Description |
Type |
Disease |
Designation |
Success Rating |
01/03/2017
|
VCEL |
|
PDUFA |
Other |
None |
|
01/07/2017
|
ANAC |
|
PDUFA |
Other |
None |
|
01/11/2017
|
TSRO |
|
PDUFA |
Oncology |
None |
|
01/29/2017
|
SGYP |
|
PDUFA |
Other |
None |
|
Q1 2017
|
SMMT |
|
Phase 2 Results |
Other |
Orphan Drug |
|
Q1 2017
|
GLMD |
|
Phase 2b Results |
Other |
None |
|
H1 2017
|
CEMP |
|
Phase 3 Results |
Infectious Disease |
None |
|
Q1 2017
|
OCRX |
|
Phase 2b Results |
Other |
Fast Track, Orphan Drug |
|
Q1 2017
|
CAPR |
|
Phase 1/2 Results |
Other |
Orphan Drug |
|
Q1 2017
|
AKAO |
|
Phase 3 Results |
Other |
Fast Track |
|